{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:04:56Z","timestamp":1772780696949,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"},{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The emergence of a novel H7N9 avian influenza that infects humans is a serious cause for concern. Of the genome sequences of H7N9 neuraminidase available, one contains a substitution of arginine to lysine at position 292, suggesting a potential for reduced drug binding efficacy. We have performed molecular dynamics simulations of oseltamivir, zanamivir and peramivir bound to H7N9, H7N9-R292K and a structurally related H11N9 neuraminidase. They show that H7N9 neuraminidase is structurally homologous to H11N9, binding the drugs in identical modes. The simulations reveal that the R292K mutation disrupts drug binding in H7N9 in a comparable manner to that observed experimentally for H11N9-R292K. Absolute binding free energy calculations with the WaterSwap method confirm a reduction in binding affinity. This indicates that the efficacy of antiviral drugs against H7N9-R292K will be reduced. Simulations can assist in predicting disruption of binding caused by mutations in neuraminidase, thereby providing a computational \u2018assay.\u2019<\/jats:p>","DOI":"10.1038\/srep03561","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T10:12:57Z","timestamp":1387534377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Computational Assay of H7N9 Influenza Neuraminidase Reveals R292K Mutation Reduces Drug Binding Affinity"],"prefix":"10.1038","volume":"3","author":[{"given":"Christopher J.","family":"Woods","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maturos","family":"Malaisree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"McIntosh-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian J.","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,20]]},"reference":[{"key":"BFsrep03561_CR1","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","volume":"368","author":"R Gao","year":"2013","unstructured":"Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368, 1888\u20131897 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep03561_CR2","doi-asserted-by":"crossref","first-page":"20452","DOI":"10.2807\/ese.18.15.20452-en","volume":"18","author":"A Nicoll","year":"2013","unstructured":"Nicoll, A. & Danielsson, N. A novel reassortant avian influenza A (H7N9) virus in China - What are the implications for Europe. Euro Surveill. 18, 20452 (2013).","journal-title":"Euro Surveill."},{"key":"BFsrep03561_CR3","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0140-6736(13)60903-4","volume":"381","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381, 1916\u20131925 (2013).","journal-title":"Lancet"},{"key":"BFsrep03561_CR4","doi-asserted-by":"crossref","unstructured":"Lam, T. T. et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature in press (2013).","DOI":"10.1038\/nature12515"},{"key":"BFsrep03561_CR5","doi-asserted-by":"publisher","first-page":"f4752","DOI":"10.1136\/bmj.f4752","volume":"347","author":"X Qi","year":"2013","unstructured":"Qi, X. et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 347, f4752 (2013).","journal-title":"BMJ"},{"key":"BFsrep03561_CR6","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1038\/emi.2013.27","volume":"2","author":"F Yang","year":"2013","unstructured":"Yang, F. et al. A fatal case caused by novel H7N9 avian influenza A virus in China. Emerging Microbes and Infections 2, e19 (2013).","journal-title":"Emerging Microbes and Infections"},{"key":"BFsrep03561_CR7","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMp1304661","volume":"368","author":"TM Uyeki","year":"2013","unstructured":"Uyeki, T. M. & Cox, N. J. Global concerns regarding novel influenza A (H7N9) virus infections. N. Engl. J. Med. 368, 1862\u20131864 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep03561_CR8","first-page":"109","volume":"7","author":"SH Lu","year":"2013","unstructured":"Lu, S. H. et al. Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9). Biosci. Trends. 7, 109\u2013112 (2013).","journal-title":"Biosci. Trends."},{"key":"BFsrep03561_CR9","doi-asserted-by":"crossref","first-page":"20453","DOI":"10.2807\/ese.18.15.20453-en","volume":"18","author":"T Kageyama","year":"2013","unstructured":"Kageyama, T. et al. Genetic analysis of novel avian A (H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 18, 20453 (2013).","journal-title":"Euro Surveill."},{"key":"BFsrep03561_CR10","doi-asserted-by":"crossref","first-page":"20461","DOI":"10.2807\/ese.18.16.20461-en","volume":"18","author":"V Corman","year":"2013","unstructured":"Corman, V. et al. Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A (H7N9) strain associated with human spillover infections in China. Euro Surveill. 18, 20461 (2013).","journal-title":"Euro Surveill."},{"key":"BFsrep03561_CR11","unstructured":"Li, Q. et al. Preliminary report: epidemiology of the avian influenza A (H7N9) outbreak in China. N. Engl. J. Med. In Press (2013)."},{"key":"BFsrep03561_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.micinf.2013.04.004","volume":"15","author":"Q Liu","year":"2013","unstructured":"Liu, Q. et al. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes. Infect. 15, 432\u2013439 (2013).","journal-title":"Microbes. Infect."},{"key":"BFsrep03561_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","volume":"98","author":"M Samson","year":"2013","unstructured":"Samson, M., Pizzorno, A., Abed, Y. & Boivin, G. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res. 98, 174\u2013185 (2013).","journal-title":"Antiviral Res."},{"key":"BFsrep03561_CR14","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(13)61125-3","volume":"381","author":"Y Hu","year":"2013","unstructured":"Hu, Y. et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet. 381, 2273\u20132279 (2013).","journal-title":"Lancet."},{"key":"BFsrep03561_CR15","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1155\/2010\/690654","volume":"21","author":"E Hansen","year":"2010","unstructured":"Hansen, E., Day, T., Arino, J., Wu, J. & Moghadas, S. M. Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks. Can. J. Infect. Dis. Med. Microbiol. 21, e28\u2013e63 (2010).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"BFsrep03561_CR16","first-page":"64","volume":"7","author":"L Mei","year":"2013","unstructured":"Mei, L. et al. Changes in and shortcomings of control strategies, drug stockpiles and vaccine development during outbreaks of avian influenza A H5N1, H1N1 and H7N9 among humans. Biosci. Trends. 7, 64\u201376 (2013).","journal-title":"Biosci. Trends."},{"key":"BFsrep03561_CR17","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3201\/eid1510.090844","volume":"15","author":"AL Wan Po","year":"2009","unstructured":"Wan Po, A. L., Farndon, P. & Palmer, N. Maximizing the value of drug stockpiles for pandemic influenza. Emerg. Infect. Dis. 15, 1686\u20131687 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"BFsrep03561_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/cid\/cis1220","volume":"56","author":"RJ Whitley","year":"2013","unstructured":"Whitley, R. J. et al. Global assessment of resistance to neuraminidase inhibitors: 2008\u20132011. The influenza resistance information study (IRIS). Clin. Infect. Dis. 56, 1197\u20131205 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep03561_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2334-11-134","volume":"11","author":"K Thorlund","year":"2011","unstructured":"Thorlund, K., Awad, T., Boivin, G. & Thabane, L. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect. Dis. 11, 134 (2011).","journal-title":"BMC Infect. Dis."},{"key":"BFsrep03561_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0969-2126(98)00075-6","volume":"6","author":"JN Varghese","year":"1998","unstructured":"Varghese, J. N. et al. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 6, 735\u2013746 (1998).","journal-title":"Structure"},{"key":"BFsrep03561_CR21","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1021\/jm010528u","volume":"45","author":"BJ Smith","year":"2002","unstructured":"Smith, B. J. et al. Structural studies of the resistance of influenza virus neuramindase to inhibitors. J. Med. Chem. 45, 2207\u20132212 (2002).","journal-title":"J. Med. Chem."},{"key":"BFsrep03561_CR22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1128\/JVI.72.3.2456-2462.1998","volume":"72","author":"JL McKimm-Breschkin","year":"1998","unstructured":"McKimm-Breschkin, J. L. et al. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Virol. 72, 2456\u20132462 (1998).","journal-title":"J. Virol."},{"key":"BFsrep03561_CR23","doi-asserted-by":"publisher","first-page":"054114","DOI":"10.1063\/1.3519057","volume":"134","author":"CJ Woods","year":"2011","unstructured":"Woods, C. J. et al. A water-swap reaction coordinate for the calculation of absolute protein-ligand binding free energies. J. Chem. Phys. 134, 054114 (2011).","journal-title":"J. Chem. Phys."},{"key":"BFsrep03561_CR24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/pro.5560040606","volume":"4","author":"JN Varghese","year":"1995","unstructured":"Varghese, J. N., Epa, V. C. & Colman, P. M. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 4, 1081\u20131087 (1995).","journal-title":"Protein Sci."},{"key":"BFsrep03561_CR25","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1021\/bi300561n","volume":"51","author":"CJ Woods","year":"2012","unstructured":"Woods, C. J. et al. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R\/H275Y neuraminidase from H1N1-2009 influenza virus. Biochemistry 51, 4364\u20134375 (2012).","journal-title":"Biochemistry"},{"key":"BFsrep03561_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature05114","volume":"443","author":"RJ Russell","year":"2006","unstructured":"Russell, R. J. et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443, 45\u201349 (2006).","journal-title":"Nature"},{"key":"BFsrep03561_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ncomms1390","volume":"2","author":"RE Amaro","year":"2011","unstructured":"Amaro, R. E. et al. Mechanism of 150-cavity formation in influenza neuraminidase. Nat. Commun. 2, 388 (2011).","journal-title":"Nat. Commun."},{"key":"BFsrep03561_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/srep01551","volume":"3","author":"Y Wu","year":"2013","unstructured":"Wu, Y. et al. Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding. Sci. Rep. 3, 1551 (2013).","journal-title":"Sci. Rep."},{"key":"BFsrep03561_CR29","doi-asserted-by":"publisher","first-page":"e00396","DOI":"10.1128\/mBio.00396-13","volume":"4","author":"HL Yen","year":"2013","unstructured":"Yen, H. L. et al. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R\/K viral population. mBio 4, e00396\u201313 (2013).","journal-title":"mBio"},{"key":"BFsrep03561_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/prot.20660","volume":"61","author":"H Li","year":"2005","unstructured":"Li, H., Robertson, A. D. & Jensen, J. H. Very fast empirical prediction and rationalization of protein pKa values. Proteins 61, 704\u2013721 (2005).","journal-title":"Proteins"},{"key":"BFsrep03561_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"BFsrep03561_CR32","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcc.10349","volume":"24","author":"Y Duan","year":"2003","unstructured":"Duan, Y. et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24, 1999\u20132012 (2003).","journal-title":"J. Comput. Chem."},{"key":"BFsrep03561_CR33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W. & Kollman, P. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput. Chem."},{"key":"BFsrep03561_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1021\/ct200909j","volume":"8","author":"AW Goetz","year":"2012","unstructured":"Goetz, A. W. et al. Routine microsecond molecular dynamics simulations with amber on GPUs. 1. Generalized Born. J. Chem. Theory Comput. 8, 1542\u20131555 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"BFsrep03561_CR35","doi-asserted-by":"publisher","first-page":"13703","DOI":"10.1021\/jp0356620","volume":"107","author":"CJ Woods","year":"2003","unstructured":"Woods, C. J., King, M. A. & Essex, J. W. The Development of Replica-Exchange-Based Free-Energy Methods. J. Phys. Chem. B 107, 13703\u201313710 (2003).","journal-title":"J. Phys. Chem. B"},{"key":"BFsrep03561_CR36","doi-asserted-by":"publisher","first-page":"234104","DOI":"10.1063\/1.2206581","volume":"124","author":"CJ Fennell","year":"2006","unstructured":"Fennell, C. J. & Gezelter, J. D. Is the Ewald summation still necessary? Pairwise alternatives to the accepted standard for long-range electrostatics. J. Chem. Phys. 124, 234104 (2006).","journal-title":"J. Chem. Phys."},{"key":"BFsrep03561_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: Visual Molecular Dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"BFsrep03561_CR38","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/bioinformatics\/btm378","volume":"23","author":"M Seeber","year":"2007","unstructured":"Seeber, M., Cecchini, M., Rao, F., Settanni, G. & Caflisch, A. Wordom: a program for efficient analysis of molecular dynamics simulations. Bioinformatics 23, 2625\u20132627 (2007).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep03561","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep03561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep03561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:53:36Z","timestamp":1672980816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep03561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep03561"],"URL":"https:\/\/doi.org\/10.1038\/srep03561","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,20]]},"assertion":[{"value":"4 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3561"}}